CEO View | Why did I start a healthcare and cultured meat company? (Clone)
Our CEO explains how our opti-ox technology underpins not only bit.bio but also Meatable - a cultured meat company — and why we need to rethink sustainability.
28.06.2022
Published by Medium
Article
CEO View | SynBio: the opportunity for UK Life Sciences (Clone)
Our CEO writes about the importance of the synthetic biology industry as part of the UK Life Sciences vision. This was first published by the BioIndustry Association.
28.06.2022
Published by BIA
Article
CEO Views | Business and academia - the perfect partners to achieve SDGs (Clone)
28.06.2022
Published by Medium
Article
Addressing current challenges of in vitro cell models
28.06.2022
Published by bit.bio
Article
Giving you easy access to endless and reliable human cells (Clone)
28.06.2022
Published by bit.bio
Article
CEO View | Reflecting on UKRI’s first five year strategy (Clone)
28.06.2022
Published by BIA
Article
Meet bit.bio’s two new Vice Presidents of Translational Medicine (Clone)
28.06.2022
Published by bit.bio
Related pages
About usCoding cells to advance the wellbeing of humanity
